OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
5-HT3Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld‐Johnsen, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 383-412
Open Access | Times Cited: 88
Gohar Fakhfouri, Reza Rahimian, Jonas Dyhrfjeld‐Johnsen, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 383-412
Open Access | Times Cited: 88
Showing 1-25 of 88 citing articles:
The Microbiota-Gut-Brain Axis: From Motility to Mood
Kara Gross Margolis, John F. Cryan, Emeran A. Mayer
Gastroenterology (2021) Vol. 160, Iss. 5, pp. 1486-1501
Open Access | Times Cited: 654
Kara Gross Margolis, John F. Cryan, Emeran A. Mayer
Gastroenterology (2021) Vol. 160, Iss. 5, pp. 1486-1501
Open Access | Times Cited: 654
Central 5-HT receptors and their function; present and future
Trevor Sharp, Nicholas M. Barnes
Neuropharmacology (2020) Vol. 177, pp. 108155-108155
Open Access | Times Cited: 160
Trevor Sharp, Nicholas M. Barnes
Neuropharmacology (2020) Vol. 177, pp. 108155-108155
Open Access | Times Cited: 160
The neurobiology of irritable bowel syndrome
Emeran A. Mayer, Hyo Jin Ryu, Ravi R. Bhatt
Molecular Psychiatry (2023) Vol. 28, Iss. 4, pp. 1451-1465
Open Access | Times Cited: 116
Emeran A. Mayer, Hyo Jin Ryu, Ravi R. Bhatt
Molecular Psychiatry (2023) Vol. 28, Iss. 4, pp. 1451-1465
Open Access | Times Cited: 116
Reciprocal control of obesity and anxiety–depressive disorder via a GABA and serotonin neural circuit
Guobin Xia, Yong Han, Fantao Meng, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 7, pp. 2837-2853
Open Access | Times Cited: 93
Guobin Xia, Yong Han, Fantao Meng, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 7, pp. 2837-2853
Open Access | Times Cited: 93
The emerging tale of microglia in psychiatric disorders
Reza Rahimian, Marina Wakid, Liam Anuj O’Leary, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 1-29
Closed Access | Times Cited: 81
Reza Rahimian, Marina Wakid, Liam Anuj O’Leary, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 1-29
Closed Access | Times Cited: 81
The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
Rosa Maria Vitale, Fabio Arturo Iannotti, Pietro Amodeo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4876-4876
Open Access | Times Cited: 63
Rosa Maria Vitale, Fabio Arturo Iannotti, Pietro Amodeo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4876-4876
Open Access | Times Cited: 63
Asymmetric opening of the homopentameric 5-HT3A serotonin receptor in lipid bilayers
Yingyi Zhang, Patricia M. Dijkman, Rongfeng Zou, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Yingyi Zhang, Patricia M. Dijkman, Rongfeng Zou, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder
Reza Rahimian, Claudia Belliveau, Rebecca Chen, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 47
Reza Rahimian, Claudia Belliveau, Rebecca Chen, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 47
Serotonin receptors in epilepsy: Novel treatment targets?
Jo Sourbron, Lieven Lagae
Epilepsia Open (2022) Vol. 7, Iss. 2, pp. 231-246
Open Access | Times Cited: 40
Jo Sourbron, Lieven Lagae
Epilepsia Open (2022) Vol. 7, Iss. 2, pp. 231-246
Open Access | Times Cited: 40
5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders
Shvetank Bhatt, Thangaraj Devadoss, S. N. Manjula, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 9, pp. 1545-1559
Open Access | Times Cited: 65
Shvetank Bhatt, Thangaraj Devadoss, S. N. Manjula, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 9, pp. 1545-1559
Open Access | Times Cited: 65
Recent advances with 5‐HT3 modulators for neuropsychiatric and gastrointestinal disorders
Radomír Jůza, Přemysl Vlček, Eva Mezeiová, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 1593-1678
Closed Access | Times Cited: 43
Radomír Jůza, Přemysl Vlček, Eva Mezeiová, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 1593-1678
Closed Access | Times Cited: 43
Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders
Kirti Agrawal, Pratik Chakraborty, Saikat Dewanjee, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104955-104955
Closed Access | Times Cited: 27
Kirti Agrawal, Pratik Chakraborty, Saikat Dewanjee, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104955-104955
Closed Access | Times Cited: 27
Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics
Cristiano Bombardi, Annamaria Grandis, Nela Pivac, et al.
Progress in brain research (2021), pp. 83-158
Closed Access | Times Cited: 32
Cristiano Bombardi, Annamaria Grandis, Nela Pivac, et al.
Progress in brain research (2021), pp. 83-158
Closed Access | Times Cited: 32
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
Brittney H. Davis, T. Mark Beasley, Michelle D. Amaral, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 5, pp. 1368-1380
Open Access | Times Cited: 30
Brittney H. Davis, T. Mark Beasley, Michelle D. Amaral, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 5, pp. 1368-1380
Open Access | Times Cited: 30
Ferroptosis: A New Pathway in the Interaction between Gut Microbiota and Multiple Sclerosis
Junjie Jian, Jun Wei
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
Junjie Jian, Jun Wei
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor
Eleftherios Zarkadas, Hong Zhang, Wensheng Cai, et al.
Structure (2020) Vol. 28, Iss. 10, pp. 1131-1140.e4
Open Access | Times Cited: 30
Eleftherios Zarkadas, Hong Zhang, Wensheng Cai, et al.
Structure (2020) Vol. 28, Iss. 10, pp. 1131-1140.e4
Open Access | Times Cited: 30
Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
Gustavo Roberto Villas Boas, Stefânia Neiva Lavorato, Marina Meirelles Paes, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 148-148
Open Access | Times Cited: 27
Gustavo Roberto Villas Boas, Stefânia Neiva Lavorato, Marina Meirelles Paes, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 148-148
Open Access | Times Cited: 27
Serotonin and Depression: Scrutiny of New Targets for Future Anti- Depressant Drug Development
Arzoo Pannu, Ramesh K. Goyal
Current Drug Targets (2023) Vol. 24, Iss. 10, pp. 816-837
Closed Access | Times Cited: 10
Arzoo Pannu, Ramesh K. Goyal
Current Drug Targets (2023) Vol. 24, Iss. 10, pp. 816-837
Closed Access | Times Cited: 10
Structural determinants for activity of the antidepressant vortioxetine at human and rodent 5-HT3 receptors
Uriel López-Sánchez, Lachlan Munro, Lucy Kate Ladefoged, et al.
Nature Structural & Molecular Biology (2024) Vol. 31, Iss. 8, pp. 1232-1242
Closed Access | Times Cited: 3
Uriel López-Sánchez, Lachlan Munro, Lucy Kate Ladefoged, et al.
Nature Structural & Molecular Biology (2024) Vol. 31, Iss. 8, pp. 1232-1242
Closed Access | Times Cited: 3
Decoding multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations
Syeda Rida Zainab, Jehanzeb Khan, Muhammad Khalid Tipu, et al.
Neuroscience (2024)
Closed Access | Times Cited: 3
Syeda Rida Zainab, Jehanzeb Khan, Muhammad Khalid Tipu, et al.
Neuroscience (2024)
Closed Access | Times Cited: 3
Efficacy of trigger point injection for non-malignant persistent musculoskeletal pain: a narrative review
Alkisti Giannaki, Martina Rekatsina, Mohamed Salah Hassouna, et al.
Advancements in health research. (2025) Vol. 2
Closed Access
Alkisti Giannaki, Martina Rekatsina, Mohamed Salah Hassouna, et al.
Advancements in health research. (2025) Vol. 2
Closed Access
The role of 5-HT modulation in opioid withdrawal and neonatal opioid withdrawal syndrome: mechanisms and potential serotonergic targets
Kevin Lam, Gary Peltz, Walter K. Kraft
Expert Opinion on Investigational Drugs (2025)
Closed Access
Kevin Lam, Gary Peltz, Walter K. Kraft
Expert Opinion on Investigational Drugs (2025)
Closed Access
The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease
Eslam El Nebrisi, Yosra Lozon, Murat Öz
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3210-3210
Open Access
Eslam El Nebrisi, Yosra Lozon, Murat Öz
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3210-3210
Open Access
Multiple Sclerosis and Serotonin: Potential Therapeutic Applications
Aleyda M San Hernandez, Chetana Singh, Danel J Valero, et al.
Cureus (2020)
Open Access | Times Cited: 24
Aleyda M San Hernandez, Chetana Singh, Danel J Valero, et al.
Cureus (2020)
Open Access | Times Cited: 24
Hydroxy Pentacyclic Triterpene Acid, Kaempferol, Inhibits the Human 5-Hydroxytryptamine Type 3A Receptor Activity
Shinhui Lee, Hee-Soo Seol, Sanung Eom, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 544-544
Open Access | Times Cited: 15
Shinhui Lee, Hee-Soo Seol, Sanung Eom, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 544-544
Open Access | Times Cited: 15
